Megatrials for Bronchodilators in Chronic Obstructive Pulmonary Disease (COPD) Treatment: Time to Reflect

References

1. 1.↵
   1. Anthonisen NR,
   2. Connett JE,
   3. Kiley JP,
   4. et al

   . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497–505.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Kuller LH,
   2. Ockene JK,
   3. Meilahn E,
   4. Wentworth DN,
   5. Svendsen KH,
   6. Neaton JD

   . Cigarette smoking and mortality. MRFIT Research Group. Prev Med 1991;20:638–54.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Calverley PM,
   2. Rennard SI

   . What have we learned from large drug treatment trials in COPD? Lancet 2007;370:774–85.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Calverley P,
   2. Pauwels R,
   3. Vestbo J,
   4. et al

   . Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449–56.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Niewoehner DE,
   2. Rice K,
   3. Cote C,
   4. et al

   . Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005;143:317–26.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Calverley PM,
   2. Anderson JA,
   3. Celli B,
   4. et al

   . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775–89.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Tashkin DP,
   2. Celli B,
   3. Senn S,
   4. et al

   . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543–54.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Vogelmeier C,
   2. Hederer B,
   3. Glaab T,
   4. et al

   . Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011;364:1093–103.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Shrier I,
   2. Platt RW,
   3. Steele RJ

   . Mega-trials vs. meta-analysis: precision vs. heterogeneity? Contemp Clinic Trials 2007;28:324–8.

   OpenUrl
10. 10.↵
    1. Charlton BG

    . Megatrials are based on a methodological mistake. Br J Gen Pract 1996;46:429–31.

    OpenUrlAbstract/FREE Full Text